Malignant Head and Neck Mucosal Neoplasm

Malignant Head and Neck Mucosal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 80
Ph III recruiting: 9
Growth YoY: +33.3%
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (63)

clinicaltrialsPublishedShowing 51–100 of 214 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05050162	Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer	suspended	Phase 2 / Phase 3	1,714	NRG OncologyOTHER	5	Jun 25, 2026	clinicaltrials
NCT05996523	Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer	active not recruiting	Phase 2	26	National Cancer Institute (NCI)NIH	1	Jun 23, 2026